Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

FELTY’S SYNDROME

DOI: https://doi.org/10.29296/25879979-2019-07-06
Download full text PDF
Issue: 
7
Year: 
2019

S.A. Vvedensky; U.A. Khalilova; V.V. Skvortsov, MD; Yu.A. Belova Volgograd State Medical University 1, Pavshikh Bortsov Square, Volgograd 400066, Russian Federation

The paper describes Felty’s syndrome (FS) as one of the special variants of systemic rheumatoid arthritis in adults. SF occurs in patients with rheumatoid arthritis in the range from 1 to 5%. In this case, this syndrome most commonly manifests itself in women older than 40 years.
Keywords: 
rheumatoid arthritis
Felty's syndrome
treatment
symptoms
classification of rheumatoid arthritis
complications
systemic manifestations

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Nasonov E.L. Perspektivy primenenija rituksimaba pri autoimmunnyh zabolevanijah cheloveka. RMZh. 2007; 15 (26): 1958–63.
  2. Finckh A., Ciurea A., Brulhart L. et al. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis
  3. factor agents. Arthritis Rheum. 2007; 56:
  4. 1417–23. 
  5. Smolen J.S., Betteridge N., Breedveld F.C. et al. Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis. 2007; 66: 143–50.
  6. Nasonov E.L. Perspektivy primenenija monoklonal'nyh antitel k V-limfotsitam (rituksimab) pri revmatoidnom artrite. Klin. farmakol. Terapija. 2006; 1–5: 55–8.
  7. Nasonov E.L. Novye napravlenija terapii revmatoidnogo artrita: perspektivy primenenija monoklonal'nyh antitel k V-limfotsitam (rituksimab). RMZh. 2006; 25: 1778–82.
  8. Nasonov E.L. Revmatologija. Klinicheskie rekomendatsii. M.: GEOTAR-Media, 2008; 288.
  9. Nasonov E.L. Karateev D.E. Revmatoidnyj artrit. Revmatologija. Natsional'noe rukovodstvo. Pod red. E.L. Nasonova, V.A. Nasonovoj. M.: GEOTAR-Media, 2008; 852.
  10. Karateev D.E. Sovremennye vozmozhnosti dostizhenija klinicheskoj remissii pri revmatoidnom artrite. Trudnyj patsient. 2007; 11: 45–8.
  11. Amirdzhanova V.N., Lukina G.V., Nasonov E.L. Kachestvo zhizni bol'nyh revmatoidnym artritom pri primenenii anti-V-kletochnoj terapii (rezul'taty mezhdunarodnyh issledovanij i dannyh rossijskogo registra). Nauchno-praktich. revmatologija. 2009; 1: 73–8.
  12. Luchihina E.L. Rituksimab: sovremennaja terapija revmatoidnogo artrita. Sovremennaja revmatologija. 2008; 2: 74–8.